Skip to content
← All treatment topics

TREATMENT READING

Childhood Intraocular (Uveal) Melanoma

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

Health professional

Special Considerations for the Treatment of Children With Cancer

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 13, 2024. Captured 2026-09-09.

Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:

Sources: 1

Primary care physicians.

Pediatric surgeons.

Pathologists.

Pediatric radiation oncologists.

Pediatric medical oncologists and hematologists.

Ophthalmologists.

Rehabilitation specialists.

Pediatric oncology nurses.

Social workers.

Child-life professionals.

Psychologists.

Nutritionists.

For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.

Sources: Supportive and Palliative Care

The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.

Sources: 2 · NCI website

Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.

Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer

Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.

Sources: 6 · Rare Diseases Act of 2002

The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:

Sources: 7 · 8

A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]

Sources: 9

The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.

Sources: 10 · 4

These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.

Information about these tumors may also be found in sources relevant to adults with cancer, such as Intraocular (Uveal) Melanoma Treatment.

Sources: Intraocular (Uveal) Melanoma Treatment

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional

Treatment and Outcome of Childhood Intraocular (Uveal) Melanoma

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 13, 2024. Captured 2026-09-09.

Treatment options for childhood intraocular (uveal) melanoma include the following:

Surgery.

Radiation therapy.

Laser surgery.[1,2]

Sources: 1 · 2

Bispecific fusion proteins (tebentafusp).

A retrospective single-institution review identified 18 patients younger than 21 years with uveal melanoma.[3][Level of evidence C1] Patients were treated with enucleation (n = 9), transscleral en bloc resection (n = 3), plaque radiation therapy (n = 5), or proton-beam radiation therapy (n = 1).

Sources: 3 · Level of evidence C1

Eight of these patients (44%) developed metastatic disease, all of whom died of their disease. The median survival time after detection of metastasis was 2.3 months (95% confidence interval [CI], 0.0–5.2 months).

The median overall survival (OS) of the 18 patients after treatment of the primary intraocular tumors was 11.9 years (95% CI, 7.3–16.5 years).

Laser surgery has been used to treat childhood intraocular melanoma.[1,2]

Sources: 1 · 2

An open-label, randomized, phase III trial of adult patients with previously untreated HLA-A*02:01–positive metastatic uveal melanoma investigated treatment with tebentafusp. Tebentafusp is a bispecific restricted T-cell receptor for the glycoprotein 100 peptide; it is fused to a CD3 single-chain variable fragment. Patients were randomly assigned to receive either tebentafusp or treatment according to the investigator's choice.[4]

Sources: 4

Patients who received tebentafusp had an OS rate of 73%, compared with 50% for patients in the control group (hazard ratio [HR] for death, 0.51; P < .001).

The progression-free survival rate was also significantly higher for the tebentafusp group (31% vs. 16% at 6 months; HR for progression or death, 0.71; P = .01).

The most common toxicities for patients who received tebentafusp were cytokine release syndrome, mostly grades 1 and 2, and rash.

For information about the treatment of uveal melanoma in adults, see Intraocular (Uveal) Melanoma Treatment.

Sources: Intraocular (Uveal) Melanoma Treatment

Health professional

Treatment Options Under Clinical Evaluation for Childhood Intraocular (Uveal) Melanoma

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: August 13, 2024. Captured 2026-09-09.

Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.

Sources: NCI website · ClinicalTrials.gov website

For patients · Stages of Childhood Intraocular Melanoma

Sometimes intraocular melanoma comes back after treatment.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

The cancer may come back in the eye or in other parts of the body, such as in the lung or liver.

Sources: lung

For patients

Treatment Option Overview

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

For patients · Treatment Option Overview

Key Points

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

There are different types of treatment for children with intraocular melanoma.

Children with intraocular melanoma should have their treatment planned by a team of doctors who are experts in treating childhood cancer.

Three types of standard treatment are used:

Three types of standard treatment are used:

Surgery

Radiation therapy

Laser surgery

New types of treatment are being tested in clinical trials.

New types of treatment are being tested in clinical trials.

Targeted therapy

Treatment for childhood intraocular melanoma may cause side effects.

Patients may want to think about taking part in a clinical trial.

Patients can enter clinical trials before, during, or after starting their cancer treatment.

Follow-up tests may be needed.

For patients · Treatment Option Overview

There are different types of treatment for children with intraocular melanoma.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.

Sources: standard · clinical trials · research study

Because cancer in children is rare, taking part in a clinical trial should be considered. Some clinical trials are open only to patients who have not started treatment.

For patients · Treatment Option Overview

Children with intraocular melanoma should have their treatment planned by a team of doctors who are experts in treating childhood cancer.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

Treatment will be overseen by a pediatric oncologist, a doctor who specializes in treating children with cancer. The pediatric oncologist works with other pediatric health professionals who are experts in treating children with cancer and who specialize in certain areas of medicine. This may include the following specialists and others:

Sources: pediatric oncologist · cancer · pediatric · medicine · specialists

Pediatrician.

Sources: Pediatrician

Pediatric surgeon.

Sources: Pediatric surgeon

Radiation oncologist.

Sources: Radiation oncologist

Pediatric ophthalmologist.

Sources: ophthalmologist

Social worker.

Sources: Social worker

Rehabilitation specialist.

Sources: Rehabilitation specialist

Psychologist.

Sources: Psychologist

Child-life specialist.

Sources: Child-life specialist

For patients · Treatment Option Overview

Three types of standard treatment are used:

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

For patients · Treatment Option Overview / Three types of standard treatment are used:

Surgery

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

During surgery, all or part of the eye with cancer is removed. Whether all or part of the eye is removed during surgery depends on the size of the cancer and where it is in the eye.

Sources: surgery

For patients · Treatment Option Overview / Three types of standard treatment are used:

Radiation therapy

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:

Sources: Radiation therapy · x-rays · radiation · cells

External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.

Sources: External radiation therapy

Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. For intraocular melanoma, localized plaque radiation therapy is used. Radioactive seeds are attached to one side of a disk, called a plaque, and placed directly on the outside wall of the eye near the tumor. The side of the plaque with the seeds on it faces the eyeball, aiming radiation at the tumor. The plaque helps protect other nearby tissue from the radiation.

Sources: Internal radiation therapy · radioactive · seeds · catheters · intraocular melanoma · localized · plaque radiation therapy · tumor · tissue

For patients · Treatment Option Overview / Three types of standard treatment are used:

Laser surgery

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

Laser surgery uses a laser beam (a narrow beam of intense light) to turn the cancer cells into a gas that evaporates (dissolves into the air).

Sources: Laser surgery · laser beam

For patients · Treatment Option Overview

New types of treatment are being tested in clinical trials.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.

Sources: clinical trials · NCI website

For patients · Treatment Option Overview / New types of treatment are being tested in clinical trials.

Targeted therapy

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. Targeted therapies usually cause less harm to normal cells than chemotherapy or radiation therapy do.

Sources: Targeted therapy · drugs · chemotherapy

Targeted therapy is being studied for the treatment of childhood intraocular melanoma that has recurred (come back).

Sources: recurred

For patients · Treatment Option Overview

Treatment for childhood intraocular melanoma may cause side effects.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

To learn more about side effects that begin during treatment for cancer, visit Side Effects.

Sources: side effects · Side Effects

For patients · Treatment Option Overview

Patients may want to think about taking part in a clinical trial.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.

Sources: clinical trial · standard treatment

Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.

Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.

For patients · Treatment Option Overview

Patients can enter clinical trials before, during, or after starting their cancer treatment.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.

Sources: side effects

Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s clinical trials search webpage. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.

Sources: clinical trials search · ClinicalTrials.gov

For patients · Treatment Option Overview

Follow-up tests may be needed.

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

As your child goes through treatment, they will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.

Sources: diagnose · stage

Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your child's condition has changed or if the cancer has recurred (come back).

For patients

Treatment of Childhood Intraocular Melanoma

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

For information about the treatments listed below, see the Treatment Option Overview section.

Sources: Treatment Option Overview

Treatment of newly diagnosed intraocular melanoma in children is like treatment for adults and may include the following:

Sources: diagnosed · intraocular melanoma

Surgery to remove the tumor.

Sources: Surgery · tumor

Radiation therapy.

Sources: Radiation therapy

Laser surgery.

Sources: Laser surgery

See the PDQ summary on adult Intraocular (Uveal) Melanoma Treatment for more information.

Sources: PDQ · Intraocular (Uveal) Melanoma Treatment

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

For patients

Treatment of Recurrent Childhood Intraocular Melanoma

Source: Childhood Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: August 24, 2021. Captured 2026-09-09.

For information about the treatments listed below, see the Treatment Option Overview section.

Sources: Treatment Option Overview

Treatment of recurrent intraocular melanoma in children may include the following:

Sources: recurrent · intraocular melanoma

A clinical trial that checks a sample of the patient's tumor for certain gene changes. The type of targeted therapy that will be given to the patient depends on the type of gene change.

Sources: clinical trial · tumor · gene · targeted therapy

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

Disease and treatment settings

Childhood Intraocular (Uveal) Melanoma

Disease and treatment setting

Intraocular (Uveal) Melanoma in children and adolescents

recurrent Childhood Intraocular (Uveal) Melanoma

Disease and treatment setting

Treatment of Recurrent Childhood Intraocular Melanoma